Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells.
(Q39711077)
scientific article published on 24 April 2010
scientific article published on 24 April 2010
Language:
Current Data About
Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells.